More Information

Facilitating patient access to our medicines depends upon securing full regulatory approval of Gilead's antiretroviral products in Access Program countries. Regulatory approval makes it possible to import and distribute the medicines, and enables health ministries to include Gilead products in national treatment guidelines. Therefore, we submit unique product registration dossiers conforming to the format and content requirements of each country.

For the full list of product registrations approved, filed and pending submission, click here.